Kardium

Vancouver, Canada Founded: 2007 • Age: 19 yrs
Atrial fibrillation ablation devices are developed by Kardium.
Request Access

About Kardium

Kardium is a company based in Vancouver (Canada) founded in 2007 by Sam Lichtenstein, Dan Gelbart, and Doug Goertzen.. Kardium has raised $471.44 million across 6 funding rounds from investors including Fidelity Investments, T. Rowe Price and Janus Henderson Investors. Kardium offers products and services including Globe Pulsed Field System. Kardium operates in a competitive market with competitors including Argá Medtech, Adagio Medical, Farapulse, Affera and Field Medical, among others.

  • Headquarter Vancouver, Canada
  • Founders Sam Lichtenstein, Dan Gelbart, Doug Goertzen
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Kardium Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $471.44 M (USD)

    in 6 rounds

  • Latest Funding Round
    $250 M (USD), Series C

    Jul 08, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kardium

Kardium offers a comprehensive portfolio of products and services, including Globe Pulsed Field System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Catheter for atrial fibrillation ablation and mapping in real-time.

People of Kardium
Headcount 50-200
Employee Profiles 39
Board Members and Advisors 9
Employee Profiles
People
Kevin Chaplin
CEO
People
Doug Goertzen
President & COO
People
Joy-Gen Nakamura
Field Clinical Trial Specialist
People
Fabio Aguiar
Senior Manager, Quality Control

Unlock access to complete

Board Members and Advisors
people
Hans Kottkamp
Medical Advisor
people
Dan Gelbart
Advisor
people
Amos Michelson
Co-founder And Chairman
people
Atul Verma
Medical Advisor

Unlock access to complete

Funding Insights of Kardium

Kardium has successfully raised a total of $471.44M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $250 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series C — $250.0M
  • First Round

    (22 Jul 2010)

  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2025 Amount Series C - Kardium Valuation Janus Henderson Investors
Jun, 2024 Amount Series B - Kardium Valuation Fidelity Investments
Dec, 2020 Amount Series B - Kardium Valuation Fidelity Investments
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Kardium

Kardium has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, T. Rowe Price and Janus Henderson Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment management services are offered by Durable Capital Partners.
Founded Year Domain Location
Multiple sectors are targeted for venture capital investments.
Founded Year Domain Location
Eventide is engaged in values-based investment management services.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Kardium

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Kardium

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Kardium Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Kardium

Kardium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Argá Medtech, Adagio Medical, Farapulse, Affera and Field Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Medical devices for cardiac arrhythmias are developed by Argá Medtech.
domain founded_year HQ Location
Cardiovascular therapies are developed by Adagio Medical in stealth mode.
domain founded_year HQ Location
Devices for cardiac ablation via pulsed field technology are developed.
domain founded_year HQ Location
Devices for treating heart rhythm disorders are developed.
domain founded_year HQ Location
Pulsed electric field ablation devices for heart arrhythmias are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Kardium

Frequently Asked Questions about Kardium

When was Kardium founded?

Kardium was founded in 2007 and raised its 1st funding round 3 years after it was founded.

Where is Kardium located?

Kardium is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.

Is Kardium a funded company?

Kardium is a funded company, having raised a total of $471.44M across 6 funding rounds to date. The company's 1st funding round was a Series B of $116.3M, raised on Jul 22, 2010.

What does Kardium do?

Kardium was founded in 2007 in Vancouver, Canada, within the medical device sector. Focus is placed on the Globe mapping and ablation system, an investigational tool for diagnosing and treating atrial fibrillation. Cardiac tissue mapping, stimulation, and radiofrequency ablation are enabled by the device. Operations center on advancing cardiac electrophysiology solutions for clinical use.

Who are the top competitors of Kardium?

Kardium's top competitors include Adagio Medical, Field Medical and Argá Medtech.

What products or services does Kardium offer?

Kardium offers Globe Pulsed Field System.

Who are Kardium's investors?
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available